Noveltreat 0.5mg Injection
Available Pack Sizes
Free Shipping
Order above $200.00
Worldwide Delivery
8-10 Business Days
24/7 Support
Solve your queries
- 100% Genuine Medicines
- Secure International Logistics
- Secure Payment
- Authentic Pharmaceutical Supplier
How to Order from Medionix Pharma
Add Products
Browse our medicines and add the required products to your cart.
Add Products to Cart
Order Method
Place your order easily through WhatsApp or Email support.
Choose Your Ordering Method
Share Details
Provide your delivery address and contact information.
Share Delivery & Prescription Details
Order Dispatched
Your order is packed securely and shipped worldwide.
Order Confirmation & Dispatch
Noveltreat 0.5mg Injection
contains Semaglutide 0.5mg in a once-weekly pre-filled pen manufactured by Knoll Pharma. This is the first therapeutic maintenance dose of Noveltreat injectable semaglutide, initiated after 4 weeks on the 0.25mg starting dose. At 0.5mg, clinically meaningful weight reduction and HbA1c improvements begin to accumulate while remaining affordable for Indian patients.
Benefits:
- First therapeutic dose of Noveltreat semaglutide with measurable clinical benefit
- Average HbA1c reduction of ~1.5% and meaningful weight loss at maintenance
- Once-weekly injection for superior convenience and adherence
- Highly cost-effective Indian alternative to imported 0.5mg semaglutide injections
- Manufactured by Knoll Pharma under regulatory-approved quality standards
How It Works:
At 0.5mg, semaglutide achieves sufficient GLP-1 receptor occupancy to deliver robust insulin secretion stimulation, meaningful glucagon suppression, and significant central appetite inhibition. Gastric emptying is markedly slowed, extending satiety after meals. The extended half-life ensures stable weekly drug levels for consistent metabolic benefit between doses.
Dosage and Administration:
Inject 0.5mg subcutaneously once weekly after completing the 0.25mg initiation period. Administer into the abdomen, thigh, or outer upper arm at any time of day. Rotate sites each week. If further glycaemic or weight control is needed, the prescriber may escalate to 1mg after 4 weeks.
Side Effects:
Common: nausea, diarrhoea, vomiting, decreased appetite, constipation, abdominal pain. Injection-site: transient redness or discomfort. Uncommon: increased resting heart rate, headache. Serious: pancreatitis, cholelithiasis.
Precautions:
Contraindicated in history of medullary thyroid carcinoma or MEN2. Monitor closely when co-administered with insulin or sulphonylureas due to hypoglycaemia risk. Ensure adequate hydration during bouts of nausea and vomiting.
Noveltreat Dosage Comparison Guide
| Strength | Best For | Onset | Duration | Link |
|---|---|---|---|---|
| 0.25mg | Lower strength option | 2–4 wks | Weekly | View → |
| 0.5mg | Standard strength option | 2–4 wks | Weekly | Current |
| 1mg | Popular strength option | 2–4 wks | Weekly | View → |
| 1.7mg | Higher strength option | 2–4 wks | Weekly | View → |
| 2.4mg | Maximum strength variant | 2–4 wks | Weekly | View → |
* Always consult your doctor before changing your dosage. This information is for educational reference only.
Frequently Asked Questions
Q1: What is Noveltreat 0.5mg used for?
Noveltreat 0.5mg is the first therapeutic maintenance dose of injectable semaglutide from Knoll Pharma, providing meaningful weight loss support and glycaemic control in type 2 diabetes after the 4-week 0.25mg initiation period.
Q2: How much cheaper is Noveltreat 0.5mg than Ozempic 0.5mg?
Noveltreat 0.5mg from Knoll Pharma is typically 70–80% less expensive than branded Ozempic 0.5mg, making ongoing semaglutide therapy significantly more accessible for patients in India.
Q3: Is Noveltreat 0.5mg as effective as Ozempic 0.5mg?
Yes. Noveltreat 0.5mg is bioequivalent to the originator 0.5mg semaglutide injection. Both contain identical drug substance at the same dose and produce the same clinical outcomes.
Q4: Can Noveltreat 0.5mg be used by patients with heart failure?
Semaglutide has not shown adverse effects in patients with stable heart failure and is generally considered safe. Patients with severe heart failure should use GLP-1 agonists under specialist supervision.
Q5: What are the injection sites for Noveltreat?
Approved sites are the subcutaneous fat of the lower abdomen (at least 2 inches from the navel), front of the upper thigh, or outer upper arm. Rotate among these sites weekly to prevent local tissue reactions.
Q6: Can Noveltreat 0.5mg be used during Ramadan?
The once-weekly injection can be administered at any time, making it compatible with daytime fasting during Ramadan. Many patients choose to inject after the evening meal (iftar) during the holy month. Discuss any adjustments with your prescriber.
Q7: What should I do if my Noveltreat pen looks cloudy?
Semaglutide injection should be clear and colourless to slightly yellow. Do not use if it appears cloudy, discoloured, or contains visible particles. Contact your pharmacist for a replacement pen.
Q8: Can I reduce pain from Noveltreat injections?
Allow the pen to reach room temperature before injecting. Inject at a clean, dry site, avoid injecting into irritated or bruised skin, and insert the needle quickly and confidently. Rotating sites prevents local sensitisation.
Q9: Does Noveltreat 0.5mg affect cholesterol?
Semaglutide produces favourable lipid changes as a secondary metabolic effect — lower LDL, lower triglycerides, and higher HDL — largely driven by weight loss and improved glycaemic control.
Q10: Is Knoll Pharma a reliable manufacturer?
Knoll Pharma is a DCGI-licensed Indian pharmaceutical manufacturer producing a range of injectable and oral medicines for domestic and international markets, operating under WHO-GMP and Schedule M quality standards.
Customer Reviews
Metro Hospital Pharmacy
UK · 2 weeks ago
“Reliable supplier. Product met all our quality standards. Great communication throughout the entire procurement process.”
Global Meds Supply
Germany · 6 weeks ago
“Ordering from Medionix for several months now. Consistent pharmaceutical quality and professional service every time.”
Thomas B.
Australia · 4 months ago
“Legitimate pharmaceutical supplier. Packaging intact, expiry dates clearly printed, batch numbers traceable. Very satisfied.”
Robert Chen
Canada · 1 month ago
“Very satisfied with the order. Packaging was secure and delivery was on time. Quality matches the description perfectly.”
Dr. Emily Parker
UK · 2 months ago
“Impressed with the professionalism. Certificate of Analysis provided on request. Will be placing repeat orders for our clinic.”
Related Products
Disclaimer
The information provided on Medionix Pharma is intended for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or starting any treatment.
Medionix Pharma does not encourage self-medication. Customers are responsible for ensuring that purchases comply with local laws and prescription requirements in their country. If you have any questions or concerns regarding the content on our website, please contact us at sales@medionixpharma.com.